Quality of life outcomes in left ventricular assist system inpatients and outpatients

This study empirically evaluates the quality of life (QOL) effects associated with hospital discharge among heart transplant candidates whose lives are maintained by left ventricular support systems (LVAS). Thirty-five LVAS inpatients (18 Novacor, 17 Thoratec) received structured QOL assessments approximately 1 month after device implant. Ten of the patients (8 Novacor, 2 Thoratec) were subsequently discharged to either home or a home-like outpatient facility where their QOL was reassessed. The QOL of LVAS patients, before and after discharge, was compared with that of demographically similar nonhospitalized heart transplant candidates (n = 55) and recipients (n = 97). Their caregivers' QOL was also assessed. The QOL of LVAS outpatients showed statistically significant (p < 0.05) advantages over remaining LVAS inpatients and nonhospitalized heart candidates. Advantages appeared in physical, emotional, and social functioning domains. The QOL of LVAS outpatients also improved (p < 0.05) over their own QOL before discharge, with the greatest change in physical functional and emotional status. The QOL of LVAS outpatients most closely resembled QOL in the transplant recipients. Family caregivers to LVAS outpatients reported some increases in caregiving burden after patient discharge, but their overall well being was not adversely affected. These data provide an empiric basis for the provision of outpatient programs as appropriate care for eligible LVAS patients.